These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17434008)

  • 1. Update on therapeutic monoclonal antibodies.
    Bussel JB; Giulino L; Lee S; Patel VL; Sandborg C; Stiehm ER
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr; 37(4):118-35. PubMed ID: 17434008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?
    Ballow M
    J Allergy Clin Immunol; 2005 Oct; 116(4):738-43. PubMed ID: 16210044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monoclonal antibodies and therapeutics].
    Desgranges C
    Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell depletion in autoimmune rheumatic diseases.
    Pitashny M; Shoenfeld Y
    Autoimmun Rev; 2005 Sep; 4(7):436-41. PubMed ID: 16137609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the development of therapeutic anti-cytokine antibodies.
    Reichert JM
    Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?
    Kelly KM; Pritchard J
    Br J Cancer Suppl; 1994 Sep; 23():S54-5. PubMed ID: 8075008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic targets along the Th17 pathway.
    Ouyang W; Filvaroff E; Hu Y; Grogan J
    Eur J Immunol; 2009 Mar; 39(3):670-5. PubMed ID: 19283720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mAbs in nonlupus autoimmune rheumatic disease.
    Whelan BR; Isenberg DA
    Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in the immunotherapy of autoimmune diseases.
    Perosa F; Luccarelli G; Prete M; Dammacco F
    Ann Ital Med Int; 2001; 16(4):220-32. PubMed ID: 11799630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies in rheumatic diseases.
    Yuvienco C; Schwartz S
    Med Health R I; 2011 Nov; 94(11):320-4. PubMed ID: 22204094
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease.
    Prete M; Perosa F; Favoino E; Dammacco F
    Clin Exp Med; 2005 Dec; 5(4):141-60. PubMed ID: 16362794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotechnological drugs: the breakthrough in autoimmune rheumatic conditions.
    Cavagna L; Saketkoo LA; Schwarting A; Caporali R
    Biomed Res Int; 2014; 2014():481973. PubMed ID: 25180183
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibody therapy of inflammatory rheumatic diseases.
    Breedveld FC; van der Lubbe PA
    Br Med Bull; 1995 Apr; 51(2):493-502. PubMed ID: 7552078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.
    Chin LT; Chu C; Chen HM; Wang DW; Liao SK
    Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies. Principles, generation, application, and side effects].
    Sack U; Emmrich F
    Internist (Berl); 2008 Aug; 49(8):919-20, 921-4, 926-8. PubMed ID: 18587546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.